Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes The UFDI team is dedicated to improving the lives of people affected by type 1 diabetes (T1D). Over the last 25 years, UFDI investigators have played a major role in nearly every clinical trial that has demonstrated a novel…
